CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Fusobacterium nucleatum: The Opportunistic Pathogen of Periodontal and Peri-Implant Diseases

Chen, Yanchi, Shi, Tao, Li, Yiling, Huang, Linyang, Yin, Derong·2022·Frontiers in Microbiology
DOI 10.3389/fmicb.2022.860149PMC PMC8966671
Open this paper in CoChat — free account

Abstract

Peri-implant diseases are considered to be a chronic destructive inflammatory destruction/damage occurring in soft and hard peri-implant tissues during the patient’s perennial use after implant restoration and have attracted much attention because of their high incidence. Although most studies seem to suggest that the pathogenesis of peri-implant diseases is similar to that of periodontal diseases and that both begin with microbial infection, the specific mechanism of peri-implant diseases remains unclear. As an oral opportunistic pathogen, Fusobacterium nucleatum ( F. nucleatum ) has been demonstrated to be vital for the occurrence and development of many oral infectious diseases, especially periodontal diseases. More notably, the latest relevant studies suggest that F. nucleatum may contribute to the occurrence and development of peri-implant diseases. Considering the close connection between peri-implant diseases and periodontal diseases, a summary of the role of Fusobacterium nucleatum in periodontal diseases may provide more research directions and ideas for the peri-implantation mechanism. In this review, we summarize the effects of F. nucleatum on periodontal diseases by biofilm formation, host infection, and host response, and then we establish the relationship between periodontal and peri-implant diseases. Based on the above aspects, we discuss the importance and potential value of F. nucleatum in peri-implant diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2022.860149

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The bridging function of Fusobacterium nucleatum in biofilm formation. Fusobacterium nucleatum is a bridging organism that has a great ability to bind to many other microorganisms. In the oral cavity, Fusobacterium nucleatum adheres to both early and late colonizers, promoting the coaggregation of periodontal disease-related pathogens. In addition, it can bind to Candida albicans and Clostridioides difficile. RadD is one of the most profoundly studied adhesions of Fusobacterium nucleatum and contributes to the binding between Fusobacterium nucleatum and Candida albicans, Streptococcus cristatus, Streptococcus gordonii, Streptococcus mutans, Actinomyces naeslundii, Porphyromonas gingivalis, and Clostridioides difficile via an arginine-inhibitable method. Several other Fusobacterium nucleatum outer membrane proteins are also vital in bacterial coaggregation and biofilm formation, including Fap2, FomA and CmpA. Moreover, the Fusobacterium nucleatum outer membrane lectin also contributes to dual-species biofilm formation in a galactose-inhibitable method.
Figure 1 The bridging function of Fusobacterium nucleatum in biofilm formation. Fusobacterium nucleatum is a bridging organism that has a great ability to bind to many other microorganisms. In the oral cavity, Fusobacterium nucleatum adheres to both early and late colonizers, promoting the coaggregation of periodontal disease-related pathogens. In addition, it can bind to Candida albicans and Clostridioides difficile. RadD is one of the most profoundly studied adhesions of Fusobacterium nucleatum and contributes to the binding between Fusobacterium nucleatum and Candida albicans, Streptococcus cristatus, Streptococcus gordonii, Streptococcus mutans, Actinomyces naeslundii, Porphyromonas gingivalis, and Clostridioides difficile via an arginine-inhibitable method. Several other Fusobacterium nucleatum outer membrane proteins are also vital in bacterial coaggregation and biofilm formation, including Fap2, FomA and CmpA. Moreover, the Fusobacterium nucleatum outer membrane lectin also contributes to dual-species biofilm formation in a galactose-inhibitable method.CC BY · PubMed Central
Figure 2 The mechanism by which Fusobacterium nucleatum induces host responses. (1) Under healthy conditions, one of the most important factors is that Fusobacterium nucleatum uses FAD-I to stimulate gingival epithelial cells to express human beta-defensin-2 via gingival epithelial cell Toll-like receptors. Stimulated human beta-defensin-2 helps to defend against invading microbes, including Fusobacterium nucleatum itself, and maintains homeostasis in the complex oral environment. (2) In a state of disease, Fusobacterium nucleatum destroys the epithelial barrier and affects human gingival fibroblasts. It not only induces cell autophagy but also stimulates the secretion of several cytokines and chemokines. When challenged by Fusobacterium nucleatum, the immune system is activated to eliminate invasive bacteria. However, Fusobacterium nucleatum could restrain the human immune system to reduce this removal effect. Moreover, the production of TNF-α from activated NK cells may lead to periodontal tissue destruction.
Figure 2 The mechanism by which Fusobacterium nucleatum induces host responses. (1) Under healthy conditions, one of the most important factors is that Fusobacterium nucleatum uses FAD-I to stimulate gingival epithelial cells to express human beta-defensin-2 via gingival epithelial cell Toll-like receptors. Stimulated human beta-defensin-2 helps to defend against invading microbes, including Fusobacterium nucleatum itself, and maintains homeostasis in the complex oral environment. (2) In a state of disease, Fusobacterium nucleatum destroys the epithelial barrier and affects human gingival fibroblasts. It not only induces cell autophagy but also stimulates the secretion of several cytokines and chemokines. When challenged by Fusobacterium nucleatum, the immune system is activated to eliminate invasive bacteria. However, Fusobacterium nucleatum could restrain the human immune system to reduce this removal effect. Moreover, the production of TNF-α from activated NK cells may lead to periodontal tissue destruction.CC BY · PubMed Central
Figure 3 The relationship between Fusobacterium nucleatum periodontal diseases and peri-implant diseases. Biofilms are universally accepted as mutual and critical factors in the initiation of periodontal and peri-implant diseases. The varied substrate for bacterial colonization and probably elevated function of Fusobacterium nucleatum in biofilm formation may be responsible for the reported discrepancies in its composition. With the succession of dental plaque, on the one hand, Fusobacterium nucleatum adheres to and/or invades host cells to induce mixed infection; on the other hand, invaded Fusobacterium nucleatum activates the human immune system to secrete inflammatory factors and accumulate inflammatory cells. These two effects cooperate with each other to elicit the ultimate inflammatory response. Detected differences between periodontal diseases and peri-implant diseases in histological structure and inflammatory response might indicate the specific pathogenesis of Fusobacterium nucleatum in these two diseases individually between the host infection and host response.
Figure 3 The relationship between Fusobacterium nucleatum periodontal diseases and peri-implant diseases. Biofilms are universally accepted as mutual and critical factors in the initiation of periodontal and peri-implant diseases. The varied substrate for bacterial colonization and probably elevated function of Fusobacterium nucleatum in biofilm formation may be responsible for the reported discrepancies in its composition. With the succession of dental plaque, on the one hand, Fusobacterium nucleatum adheres to and/or invades host cells to induce mixed infection; on the other hand, invaded Fusobacterium nucleatum activates the human immune system to secrete inflammatory factors and accumulate inflammatory cells. These two effects cooperate with each other to elicit the ultimate inflammatory response. Detected differences between periodontal diseases and peri-implant diseases in histological structure and inflammatory response might indicate the specific pathogenesis of Fusobacterium nucleatum in these two diseases individually between the host infection and host response.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 107

  1. Ahn, Caveolin-1 serves as a negative effector in senescent human gingival fibroblasts during Fusobacterium nucleatum infection, Mol Oral Microbiol, 32, 236, 10.1111/omi.12167 · DOI
  2. Ahn, Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection, PLoS One, 12, e0188755, 10.1371/journal.pone.0188755 · DOI
  3. Albrektsson, 2016, “Peri-Implantitis”: a complication of a foreign body or a man-made “disease”. Facts and fiction, Clin. Implant. Dent. Relat. Res., 18, 840, 10.1111/cid.12427 · DOI
  4. Arciola, 2018, Implant infections: adhesion, biofilm formation and immune evasion, Nat. Rev. Microbiol., 16, 397, 10.1038/s41579-018-0019-y · DOI
  5. Belibasakis, 2014, Microbiological and immuno-pathological aspects of peri-implant diseases, Arch. Oral Biol., 59, 66, 10.1016/j.archoralbio.2013.09.013 · DOI
  6. Belibasakis, 2021, Microbial community-driven etiopathogenesis of peri-implantitis, J. Dent. Res., 100, 21, 10.1177/0022034520949851 · DOI · Paper page
  7. Berglundh, Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions, J. Clin. Periodontol., 45, S286, 10.1111/jcpe.12957 · DOI · Paper page
  8. Berglundh, 1991, The soft tissue barrier at implants and teeth, Clin. Oral Implants Res., 2, 81, 10.1034/j.1600-0501.1991.020206.x · DOI
  9. Bhattacharyya, 2016, FAD-I, a Fusobacterium nucleatum cell wall-associated diacylated lipoprotein that mediates human beta defensin 2 induction through toll-like receptor-1/2 (TLR-1/2) and TLR-2/6, Infect. Immun., 84, 1446, 10.1128/IAI.01311-15 · DOI
  10. Bower, 1989, Clinical and microscopic findings in edentulous patients 3 years after incorporation of osseointegrated implant-supported bridgework, J. Clin. Periodontol., 16, 580, 10.1111/j.1600-051x.1989.tb02141.x · DOI
  11. Brennan, 2019, Fusobacterium nucleatum—symbiont, opportunist and oncobacterium, Nat. Rev. Microbiol., 17, 156, 10.1038/s41579-018-0129-6 · DOI · Paper page
  12. Buser, 2017, Modern implant dentistry based on osseointegration: 50 years of progress, current trends and open questions, Periodontol., 73, 7, 10.1111/prd.12185 · DOI
  13. Busscher, 2010, Biofilm formation on dental restorative and implant materials, J. Dent. Res., 89, 657, 10.1177/0022034510368644 · DOI
  14. Carcuac, 2014, Composition of human peri-implantitis and periodontitis lesions, J. Dent. Res., 93, 1083, 10.1177/0022034514551754 · DOI
  15. Charalampakis, 2015, Microbiome of peri-implant infections: lessons from conventional, molecular and metagenomic analyses, Virulence, 6, 183, 10.4161/21505594.2014.980661 · DOI
  16. Chaushu, 2012, Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease, PLoS Pathog., 8, e1002601, 10.1371/journal.ppat.1002601 · DOI
  17. Chung, 2017, Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria, J. Microbiol. Immunol. Infect., 50, 405, 10.1016/j.jmii.2016.12.005 · DOI
  18. Dabija-Wolter, 2009, Fusobacterium nucleatum enters normal human oral fibroblasts in vitro, J. Periodontol., 80, 1174, 10.1902/jop.2009.090051 · DOI
  19. De Andrade, 2021, Differential involvement of the canonical and noncanonical inflammasomes in the immune response against infection by the periodontal bacteria Porphyromonas gingivalis and Fusobacterium nucleatum, Curr. Res. Microb. Sci., 2, 100023, 10.1016/j.crmicr.2021.100023 · DOI
  20. de Waal, 2017, Microbial characteristics of peri-implantitis: a case-control study, J. Periodontol., 88, 209, 10.1902/jop.2016.160231 · DOI
  21. Del Pozo, 2018, Biofilm-related disease, Expert Rev. Anti-Infect. Ther., 16, 51, 10.1080/14787210.2018.1417036 · DOI
  22. Dionigi, 2020, Cellular expression of DNA damage/repair and reactive oxygen/nitrogen species in human periodontitis and peri-implantitis lesions, J. Clin. Periodontol., 47, 1466, 10.1111/jcpe.13370 · DOI
  23. Donos, 2018, The periodontal pocket, Periodontol., 2000, 7, 10.1111/prd.12203 · DOI
  24. Dukka, 2021, Is bleeding on probing a reliable clinical indicator of peri-implant diseases?, J. Periodontol., 92, 1669, 10.1002/JPER.20-0890 · DOI
  25. Edwards, 2006, Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells, Infect. Immun., 74, 654, 10.1128/IAI.74.1.654-662.2006 · DOI
  26. Edwards, 2007, Association of a high-molecular weight arginine-binding protein of Fusobacterium nucleatum ATCC 10953 with adhesion to secretory immunoglobulin A and coaggregation with Streptococcus cristatus, Oral Microbiol. Immunol., 22, 217, 10.1111/j.1399-302X.2006.00343.x · DOI
  27. Engevik, 2021, Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus, Gastroenterology, 160, 1301, 10.1053/j.gastro.2020.11.034 · DOI
  28. Fardini, 2011, Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity, Mol. Microbiol., 82, 1468, 10.1111/j.1365-2958.2011.07905.x · DOI
  29. Gatti, 2008, Outcome of dental implants in partially edentulous patients with and without a history of periodontitis: a 5-year interim analysis of a cohort study, Eur. J. Oral Implantol., 1, 45, 10.1259/dmfr/75888462 · DOI
  30. Ghensi, 2020, Strong oral plaque microbiome signatures for dental implant diseases identified by strain-resolution metagenomics, NPJ Biofilms Microbiomes, 6, 47, 10.1038/s41522-020-00155-7 · DOI
  31. Ghosh, 2018, Conceptual perspectives: bacterial antimicrobial peptide induction as a novel strategy for symbiosis with the human host, Front. Microbiol., 9, 302, 10.3389/fmicb.2018.00302 · DOI
  32. Gualini, 2003, Immunohistochemical characteristics of inflammatory lesions at implants, J. Clin. Periodontol., 30, 14, 10.1034/j.1600-051x.2003.300103.x · DOI
  33. Guo, 2017, Streptococcus mutans SpaP binds to RadD of Fusobacterium nucleatum ssp. polymorphum, Mol Oral Microbiol, 32, 355, 10.1111/omi.12177 · DOI
  34. Gupta, 2010, Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation, J. Biol. Chem., 285, 36523, 10.1074/jbc.M110.133140 · DOI
  35. Gurlek, 2017, Biomarkers and bacteria around implants and natural teeth in the same individuals, J. Periodontol., 88, 752, 10.1902/jop.2017.160751 · DOI
  36. Gursoy, 2010, Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model, J. Periodontol., 81, 1084, 10.1902/jop.2010.090664 · DOI
  37. Hallstrom, 2012, Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trial, J. Clin. Periodontol., 39, 574, 10.1111/j.1600-051X.2012.01884.x · DOI
  38. Han, 2015, Fusobacterium nucleatum: a commensal-turned pathogen, Curr. Opin. Microbiol., 23, 141, 10.1016/j.mib.2014.11.013 · DOI
  39. Han, 2005, Identification and characterization of a novel adhesin unique to oral fusobacteria, J. Bacteriol., 187, 5330, 10.1128/JB.187.15.5330-5340.2005 · DOI
  40. Handley, 1991, Streptococcus crista sp. nov., a viridans streptococcus with tufted fibrils, isolated from the human oral cavity and throat, Int. J. Syst. Bacteriol., 41, 543, 10.1099/00207713-41-4-543 · DOI
  41. Horiuchi, 2020, Synergistic biofilm formation by Parvimonas micra and Fusobacterium nucleatum, Anaerobe, 62, 102100, 10.1016/j.anaerobe.2019.102100 · DOI
  42. Ivanovski, 2018, Comparison of peri-implant and periodontal marginal soft tissues in health and disease, Periodontol., 76, 116, 10.1111/prd.12150 · DOI
  43. Jang, 2017, Relatively low invasive capacity of Porphyromonas gingivalis strains into human gingival fibroblasts in vitro, Arch. Oral Biol., 83, 265, 10.1016/j.archoralbio.2017.08.007 · DOI
  44. Jiang, 2021, The temporal shift of peri-implant microbiota during the biofilm formation and maturation in a canine model, Microb. Pathog., 158, 105100, 10.1016/j.micpath.2021.105100 · DOI
  45. Johnson, 2018, Oral infection of mice with Fusobacterium nucleatum results in macrophage recruitment to the dental pulp and bone resorption, Biom. J., 41, 184, 10.1016/j.bj.2018.05.001 · DOI
  46. Kang, 2019, Fusobacterium nucleatum facilitates apoptosis, ROS generation, and inflammatory cytokine production by activating AKT/MAPK and NF-kappaB signaling pathways in human gingival fibroblasts, Oxidative Med. Cell. Longev., 2019, 1681972, 10.1155/2019/1681972 · DOI
  47. Kaplan, 2009, The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm, Mol. Microbiol., 71, 35, 10.1111/j.1365-2958.2008.06503.x · DOI
  48. Kaplan, 2010, Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes, Infect. Immun., 78, 4773, 10.1128/IAI.00567-10 · DOI
  49. Kinane, 2017, Periodontal diseases, Nat. Rev. Dis. Primers, 3, 17038, 10.1038/nrdp.2017.38 · DOI · Paper page
  50. Kinder, 1993, Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22, J. Bacteriol., 175, 840, 10.1128/jb.175.3.840-850.1993 · DOI
  51. Kotsakis, 2021, Peri-implantitis is not periodontitis: Scientific discoveries shed light on microbiome-biomaterial interactions that may determine disease phenotype, Periodontol., 86, 231, 10.1111/prd.12372 · DOI
  52. Krisanaprakornkit, 2000, Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier, Infect. Immun., 68, 2907, 10.1128/IAI.68.5.2907-2915.2000 · DOI
  53. Lee, 2012, Residual periodontal pockets are a risk indicator for peri-implantitis in patients treated for periodontitis, Clin. Oral Implants Res., 23, 325, 10.1111/j.1600-0501.2011.02264.x · DOI
  54. Leonhardt, 2003, Five-year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man, J. Periodontol., 74, 1415, 10.1902/jop.2003.74.10.1415 · DOI
  55. Leonhardt, 1999, Microbial findings at failing implants, Clin. Oral Implants Res., 10, 339, 10.1034/j.1600-0501.1999.100501.x · DOI
  56. Lima, 2017, Identification and characterization of a novel Fusobacterium nucleatum adhesin involved in physical interaction and biofilm formation with Streptococcus gordonii, Microbiology, 6, e00444, 10.1002/mbo3.444 · DOI
  57. Liu, 2014, Detection of Fusobacterium nucleatum and fadA adhesin gene in patients with orthodontic gingivitis and non-orthodontic periodontal inflammation, PLoS One, 9, e85280, 10.1371/journal.pone.0085280 · DOI
  58. Lopez, 2006, Effects of metronidazole plus amoxicillin as the only therapy on the microbiological and clinical parameters of untreated chronic periodontitis, J. Clin. Periodontol., 33, 648, 10.1111/j.1600-051X.2006.00957.x · DOI
  59. Magana, 2020, The value of antimicrobial peptides in the age of resistance, Lancet Infect. Dis., 20, e216, 10.1016/S1473-3099(20)30327-3 · DOI
  60. Martinez, 2021, Periodontal diseases and depression: a pre-clinical in vivo study, J. Clin. Periodontol., 48, 503, 10.1111/jcpe.13420 · DOI
  61. Maximo, 2009, Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies, Clin. Oral Implants Res., 20, 99, 10.1111/j.1600-0501.2008.01618.x · DOI
  62. Meng, 2021, Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity, EMBO Rep., 22, e52891, 10.15252/embr.202152891 · DOI
  63. Meyer, 2017, Experimental mucositis and experimental gingivitis in persons aged 70 or over. Clinical and biological responses, Clin. Oral Implants Res., 28, 1005, 10.1111/clr.12912 · DOI
  64. Mombelli, 2011, The characteristics of biofilms in peri-implant disease, J. Clin. Periodontol., 38, 203, 10.1111/j.1600-051X.2010.01666.x · DOI
  65. Monje, 2021, Microbial and host-derived biomarker changes during ligature-induced and spontaneous peri-implantitis in the beagle dog, J. Periodontal Res., 56, 93, 10.1111/jre.12797 · DOI
  66. Moon, 1999, The barrier between the keratinized mucosa and the dental implant. An experimental study in the dog, J. Clin. Periodontol., 26, 658, 10.1034/j.1600-051x.1999.261005.x · DOI
  67. Naruishi, 2018, Biological effects of interleukin-6 on gingival fibroblasts: cytokine regulation in periodontitis, J. Cell. Physiol., 233, 6393, 10.1002/jcp.26521 · DOI
  68. Nithianantham, 2009, Crystal structure of FadA adhesin from Fusobacterium nucleatum reveals a novel oligomerization motif, the leucine chain, J. Biol. Chem., 284, 3865, 10.1074/jbc.M805503200 · DOI
  69. Papathanasiou, 2016, Prevalence, etiology and treatment of peri-implant mucositis and peri-implantitis: a survey of periodontists in the United States, J. Periodontol., 87, 493, 10.1902/jop.2015.150476 · DOI
  70. Persson, 2014, Cluster of bacteria associated with peri-implantitis, Clin. Implant. Dent. Relat. Res., 16, 783, 10.1111/cid.12052 · DOI
  71. Pollanen, 2012, Fusobacterium nucleatum biofilm induces epithelial migration in an organotypic model of dento-gingival junction, J. Periodontol., 83, 1329, 10.1902/jop.2012.110535 · DOI
  72. Polymeri, 2021, Submucosal microbiome of peri-implant sites: a cross-sectional study, J. Clin. Periodontol., 48, 1228, 10.1111/jcpe.13502 · DOI
  73. Renvert, 2018, Peri-implant health, peri-implant mucositis, and peri-implantitis: case definitions and diagnostic considerations, J. Periodontol., 89, S304, 10.1002/JPER.17-0588 · DOI · Paper page
  74. Reyes, 2021, Porphyromonas gingivalis, Trends Microbiol., 29, 376, 10.1016/j.tim.2021.01.010 · DOI
  75. Ritzer, 2017, Diagnosing peri-implant disease using the tongue as a 24/7 detector, Nat. Commun., 8, 264, 10.1038/s41467-017-00340-x · DOI
  76. Rosen, 2008, Coaggregation of Treponema denticola with Porphyromonas gingivalis and Fusobacterium nucleatum is mediated by the major outer sheath protein of Treponema denticola, FEMS Microbiol. Lett., 289, 59, 10.1111/j.1574-6968.2008.01373.x · DOI
  77. Rosen, 2006, Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide, FEMS Microbiol. Lett., 256, 304, 10.1111/j.1574-6968.2006.00131.x · DOI
  78. Rubinstein, 2019, Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/beta-catenin modulator Annexin A1, EMBO Rep., 20, e47638, 10.15252/embr.201847638 · DOI
  79. Sahrmann, 2020, The microbiome of peri-implantitis: a systematic review and meta-analysis, Microorganisms, 8, 661, 10.3390/microorganisms8050661 · DOI
  80. Salvi, 2017, Prevalence and mechanisms of peri-implant diseases, J. Dent. Res., 96, 31, 10.1177/0022034516667484 · DOI
  81. Sanchez, 2011, Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota, J. Periodontal Res., 46, 252, 10.1111/j.1600-0765.2010.01341.x · DOI · Paper page
  82. Sandhu, 2018, Clostridioides difficile, Trends Microbiol., 26, 1049, 10.1016/j.tim.2018.09.004 · DOI
  83. Sanz-Martin, 2017, Exploring the microbiome of healthy and diseased peri-implant sites using Illumina sequencing, J. Clin. Periodontol., 44, 1274, 10.1111/jcpe.12788 · DOI
  84. Schincaglia, 2017, Clinical, immune, and microbiome traits of gingivitis and peri-implant mucositis, J. Dent. Res., 96, 47, 10.1177/0022034516668847 · DOI
  85. Smith, 2017, Chronic periodontitis and implant dentistry, Periodontol, 2000, 63, 10.1111/prd.12190 · DOI
  86. Stokowa-Soltys, 2021, Fusobacterium nucleatum—Friend or foe?, J. Inorg. Biochem., 224, 111586, 10.1016/j.jinorgbio.2021.111586 · DOI
  87. Tamura, 2013, Analysis of bacterial flora associated with peri-implantitis using obligate anaerobic culture technique and 16S rDNA gene sequence, Int. J. Oral Maxillofac. Implants, 28, 1521, 10.11607/jomi.2570 · DOI
  88. Tarnow, 2016, Increasing prevalence of peri-implantitis: how will we manage?, J. Dent. Res., 95, 7, 10.1177/0022034515616557 · DOI
  89. Temoin, 2012, Signal peptide of FadA adhesin from Fusobacterium nucleatum plays a novel structural role by modulating the filament’s length and width, FEBS Lett., 586, 1, 10.1016/j.febslet.2011.10.047 · DOI
  90. Teughels, 2006, Effect of material characteristics and/or surface topography on biofilm development, Clin. Oral Implants Res., 17, 68, 10.1111/j.1600-0501.2006.01353.x · DOI
  91. Thurnheer, 2019, Fusobacterium species and subspecies differentially affect the composition and architecture of supra- and subgingival biofilms models, Front. Microbiol., 10, 1716, 10.3389/fmicb.2019.01716 · DOI
  92. Ting, 2018, Peri-implantitis: a comprehensive overview of systematic reviews, J. Oral Implantol., 44, 225, 10.1563/aaid-joi-D-16-00122 · DOI
  93. Tonon, 2021, Anti-biofilm effect of ozonized physiological saline solution on peri-implant-related biofilm, J. Periodontol., 92, 1151, 10.1002/Jper.20-0333 · DOI
  94. Virto, 2022, Antimicrobial effects of a new brushing solution concept on a multispecies in vitro biofilm model growing on titanium surfaces, Clin. Oral Implants Res., 33, 209, 10.1111/clr.13884 · DOI
  95. Wang, 2021, Machine learning-assisted immune profiling stratifies peri-implantitis patients with unique microbial colonization and clinical outcomes, Theranostics, 11, 6703, 10.7150/thno.57775 · DOI
  96. Wassing, 2021, Modulation of human beta-defensin 2 expression by pathogenic Neisseria meningitidis and commensal lactobacilli, Antimicrob. Agents Chemother., 65, e02002, 10.1128/AAC.02002-20 · DOI
  97. Wei, 2021, Graphene-reinforced titanium enhances soft tissue seal, Front. Bioeng. Biotechnol., 9, 665305, 10.3389/fbioe.2021.665305 · DOI
  98. Wu, 2015, Cellular components mediating coadherence of Candida albicans and Fusobacterium nucleatum, J. Dent. Res., 94, 1432, 10.1177/0022034515593706 · DOI
  99. Wu, 2021, Genetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum, Proc. Natl. Acad. Sci. U. S. A., 118, e2006482118, 10.1073/pnas.2006482118 · DOI
  100. Xu, 2007, FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells, J. Biol. Chem., 282, 25000, 10.1074/jbc.M611567200 · DOI
  101. Yeh, 2019, Identification of microbiota in peri-implantitis pockets by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Sci. Rep., 9, 774, 10.1038/s41598-018-37450-5 · DOI
  102. Yin, 2007, Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human beta-defensin-2, J. Med. Microbiol., 56, 976, 10.1099/jmm.0.47198-0 · DOI
  103. Yu, 2019, Intra-oral single-site comparisons of periodontal and peri-implant microbiota in health and disease, Clin. Oral Implants Res., 30, 760, 10.1111/clr.13459 · DOI
  104. Yuan, 2021, Comparative analyses of the soft tissue interfaces around teeth and implants: insights from a pre-clinical implant model, J. Clin. Periodontol., 48, 745, 10.1111/jcpe.13446 · DOI
  105. Zhang, 2021, Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA, J. Periodontol., 10.1002/JPER.21-0144 · DOI
  106. Zhang, 2019, Metatranscriptomic analysis of an in vitro biofilm model reveals strain-specific interactions among multiple bacterial species, J. Oral Microbiol., 11, 1599670, 10.1080/20002297.2019.1599670 · DOI
  107. Zhuang, 2016, Periodontal and peri-implant microbiota in patients with healthy and inflamed periodontal and peri-implant tissues, Clin. Oral Implants Res., 27, 13, 10.1111/clr.12508 · DOI

Cited by

Sorted by citations

Metadata

Authors
Chen, Y., Shi, T., Li, Y., Huang, L., & Yin, D.
Venue
Frontiers in Microbiology
Publisher
Frontiers Media SA
Published
2022-03-11
Volume
13
ISSN
1664-302X
DOI
10.3389/fmicb.2022.860149
PMC
PMC8966671
Cited by
75
References
7
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Sichuan University (RCDWJS2021-6, RD-02-202009)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review